Respiratory Care Devices Market

Respiratory Care Devices Market by Product (Therapeutic (CPAP, Ventilator, Nebulizer, Inhaler), Pulse Oximeter, Spirometer), Indication, End User, Key Stakeholders & Expectations, Unmet Needs, Buying Criteria, Reimbursement - Global Forecast to 2028

Report Code: MD 1583 Sep, 2023, by marketsandmarkets.com

The global respiratory care devices market in terms of revenue was estimated to be worth $21.8 billion in 2023 and is poised to reach $31.8 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028. Growth in this market is largely driven by the growth in the number of patients suffering from respiratory disorders, such as COPD and asthma, increase in overweight and obese population, and rising number of preterm births. Globally, the number of preterm births has increased over the past 20 years. Pregnancy at an inappropriate age, generally over 40 years and below 20 years, increases the risk of preterm delivery. Reasons for preterm births include maternal health problems, including diabetes, high blood pressure, and massive usage of infertility treatments. Also, women belonging to specific ethnic groups are genetically prone to preterm births. For instance, the African-American and Hispanic populations in the US have a high risk of preterm births. Smoking and obesity during the pregnancy period further increase the probability of preterm births.

Attractive Opportunities in Respiratory Care Devices Market

Respiratory Care Devices Market

To know about the assumptions considered for the study, Request for Free Sample Report

Respiratory Care Devices Market

Global Respiratory Care Devices Market Dynamics

Driver: Rising Prevalence of Respiratory Diseases

Some of the major causes of COPD are long-term asthma and prolonged exposure to tobacco smoke, indoor & outdoor air pollution, and occupational fumes & dust. Other comorbid chronic conditions, including cardiovascular disease, musculoskeletal impairment, and diabetes mellitus, are related to COPD. These conditions may also impact the health status of patients, as well as interfere with COPD management. According to the WHO, in 2019, about 262 million people were suffering, and 0.5 million people died from asthma. In asthma, morbidity and mortality still remain important issues, and disease normalization is not achieved by any treatment. By 2025, it is expected that 100 million more asthmatic patients will increase globally. In the US, the condition affects 1 in every 12 people, and in Europe, there are nearly 10 million people over 45 years of age living with asthma. It is estimated that up to 1,000 people die as a result of asthma every day.

Restraint: Unfavorable reimbursement scenario

Many patients rely on reimbursements to receive treatment. The diagnostic industry, as a whole, and respiratory care diagnostics, in particular, is presently facing the challenge of a lack of reimbursements for various diagnostic tests. The Centers for Medicare & Medicaid Services (CMS) have released the 2020 Medicare Physician Fee Schedule on November 1st. As per the CMS, the final payment rates for home sleep tests are aligned with the changes initiated by the CMS. Medicare national payment rates for CPT 95800 (sleep study, heart rate, oxygen saturation, and simultaneous recording; respiratory analysis, by airflow or peripheral arterial tone; and sleep time) almost remained the same, with a 2% decline as compared to the previous year. Medicare payment amounts for CPT 95806 (unattended, simultaneous recording of sleep study, oxygen saturation, respiratory airflow, heart rate and respiratory effort, and thoracoabdominal movement) continue with a 15% decrease in global service payment from the previous year. The difference between the two codes is that CPT 95800 may include the use of Peripheral Arterial Tone technology and the requirement for the measurement of sleep time by the devices.

Opportunity: Point-of-care Diagnostics

Point-of-care (POC) testing is performed at or near the site of patient care. Improvements in the level of accuracy of tests and the increasing number of diagnostic tests for different conditions are the major factors that are providing a niche market opportunity for POC devices in respiratory diagnostics.

Increased self-testing by patients is a major factor driving the growth of the POC respiratory disease diagnostics market. Technological advancements, which are leading to devise miniaturization and enabling microfabrication processes, are expected to support the trend of POC testing and the management of respiratory diseases in the coming years. Government bodies of both developed and developing countries have recognized that POC technology provides an ideal prospect for the expansion of public healthcare networks and addressing the unmet medical needs of patients. In addition, the decreasing number of skilled technicians in the centralized system is increasing the preference for POC testing.

Challenges: Lack of patient compliance

Lack of patient compliance to CPAP therapy is a crucial factor challenging the growth of the market. Treatment compliance has always been an issue with respiratory and sleeping-related disease patients, mainly due to various issues such as lack of affordability and comfort. Patients are also not willing to bear treatment costs due to very weak reimbursements in geographies like Asia (India and China) and RoW. Non-compliance is found to be more rampant among CPAP users. Studies show that around 30% to 50% of patients experience difficulties in continuing CPAP treatments due to its claustrophobic nature. Another survey discovered that about half of CPAP patients stopped using their device within 1–3 weeks of use, with discomfort from the masks or airflow being the major reason for non-compliance with treatment.

Reimbursement Scenario

Respiratory Care Device

Description

Example

Reimbursement Scenario

Continuous Positive Airway Pressure (CPAP) Device

A device used to treat sleep apnea by delivering a continuous stream of air pressure to keep airways open during sleep.

ResMed AirSense 10

Typically covered by Medicare and private insurance. Reimbursement varies based on the payer's fee schedule and the patient's coverage. Patients may need to meet deductible and copayment requirements.

Ventilators

Mechanical devices that support breathing by delivering controlled amounts of air and oxygen to patients who cannot breathe adequately on their own.

Philips Respironics Trilogy 100

Covered by Medicare and private insurance. Reimbursement varies based on the type of ventilator, settings, and duration of use. May require prior authorization.

Nebulizers

Devices that convert liquid medication into a fine mist for inhalation, often used for respiratory conditions like asthma or COPD.

Omron MicroAir

Covered by Medicare and private insurance. Reimbursement may include the cost of the nebulizer, medication, and necessary supplies. Specific reimbursement rates depend on the insurance plan.

RESPIRATORY CARE DEVICES
Market Ecosystem

Leading players in this market include well-established and financially stable service providers of respiratory care devices. These companies have been operating in the market for several years and possess a diversified product portfolio, advanced technologies, and strong global presence. Prominent companies in this market include Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), and Medtronic plc (Ireland).

Respiratory Care Devices Market Ecosystem

The ICU ventilators segment accounted for the larger share of the respiratory care devices industry.

By type, the global respiratory care devices market is segmented into ICU ventilators and portable/transportable ventilators. The ICU ventilators segment accounted for the larger share of the ventilators market in 2022. Factors such as the rising number of intensive care beds equipped with ventilators, increasing ICU admission and re-admissions in developed countries, and the favorable reimbursement scenario are supporting the growth of the ICU ventilators segment. Due to the susceptibility of geriatric individuals to develop severe health problems, the volume of patients being treated in critical care units is increasing, which in turn is driving the demand for intensive care beds.

The COPD segment of the respiratory care devices industry is estimated to grow at a higher CAGR during the forecast period.

Based on disease indication, the global respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, infectious diseases, and other disease indications The COPD segment is estimated to grow at a higher CAGR during the forecast period. One of the major causes of COPD is tobacco smoking. According to the US Centers for Disease Control and Prevention (CDC), as many as 8 in 10 COPD-related deaths are due to smoking. Additionally, rising indoor and outdoor air pollution levels, exposure to dust and chemicals are other factors driving the prevalence of COPD.

The home care settings segment of the respiratory care devices industry is expected to grow at the highest CAGR during the forecast period.

The global respiratory care devices market is segmented into home care settings, hospitals, ambulatory care centers and other end users based on end users. Home care is the fastest-growing segment for respiratory care devices, mainly due to their convenience to patients. Sleep apnea therapeutics is one of the key markets for home care respiratory devices. The growing use of positive airway pressure devices for sleep apnea therapy is the primary contributor to the growth of this market segment.

APAC is estimated to be the fastest-growing regional market for respiratory care devices industry.

The global respiratory care devices market is segmented into Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. In 2022, APAC is estimated to be the fastest-growing regional market for respiratory care devices. The APAC market is becoming a medical tourism hub and is considered one of the fastest-growing medical procedures and devices markets. Low infrastructure and treatment costs and the availability of highly educated physicians have driven medical tourists to APAC countries, particularly India and China

Respiratory Care Devices Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The global respiratory care devices market is dominated by a few globally established players such as Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), and Medtronic plc (Ireland). Major players adopt growth strategies to expand their geographical presence and garner higher shares in the global market.

Scope of the Respiratory Care Devices Industry:

Report Metric

Details

Market Revenue in 2023

$21.8 billion

Estimated Value by 2028

$31.8 billion

Revenue Rate

Poised to grow at a CAGR of 7.8%

Market Driver

Rising Prevalence of Respiratory Diseases

Market Opportunity

Point-of-care Diagnostics

The study categorizes the global respiratory care devices market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Therapeutic Respiratory Care Devices
  • PAP Devices
  • CPAP Devices
  • APAP Devices
  • BiPAP Devices
  • Ventilators
  • ICU Ventilators
  • High-end Ventilators
  • Mid-end Ventilators
  • Basic Ventilators
  • Portable/transportable Ventilators
  • Nebulizers
  • Jet Nebulizers
  • Mesh Nebulizers
  • Ultrasonic Nebulizers
  • Humidifiers
  • Heated Humidifiers
  • Passover Humidifiers
  • Oxygen Concentrators
  • Fixed Oxygen Concentrators
  • Portable Oxygen Concentrators
  • Inhalers
  • Metered-dose Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Reusable Resuscitators
  • Nitric Oxide Delivery Units
  • Oxygen Hoods
  • Monitoring Devices
  • Pulse Oximeters
  • Pulse Oximeter Sensors
  • Pulse Oximeter Equipment
  • Capnographs
  • Gas Analyzers
  • Diagnostic Respiratory Care Devices
  • Spirometers
  • Polysomnography Devices (PSG Devices)
  • Peak Flow Meters
  • Other Diagnostic Devices
  • Consumables & Accessories
  • Masks
  • Reusable Masks
  • Disposable Masks
  • Disposable Resuscitators
  • Tracheostomy Tubes
  • Breathing Circuits
  • Nasal Cannulae
  • Other Consumables & Accessories

By Disease Indication

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Sleep Apnea
  • Asthma
  • Infectious Diseases
  • Other Disease Indications

By End User

  • Hospitals
  • Home Care Settings
  • Ambulatory Care Centers (ACCs)
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 55)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 RESPIRATORY CARE DEVICES MARKET SEGMENTATION
                    FIGURE 2 RESPIRATORY CARE DEVICES INDUSTRY, BY REGION
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
          TABLE 1 ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2018–2022
    1.5 STAKEHOLDERS 
    1.6 LIMITATIONS 
    1.7 SUMMARY OF CHANGES 
    1.8 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 60)
    2.1 RESEARCH DATA 
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V.
          FIGURE 10 SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2022)
          FIGURE 11 DEMAND-SIDE MARKET ESTIMATION: VENTILATORS MARKET (2022)
          FIGURE 12 TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES INDUSTRY
          FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
          FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
          FIGURE 15 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY
    2.4 STUDY ASSUMPTIONS 
           2.4.1 MARKET SHARE ASSUMPTIONS
           2.4.2 RESEARCH ASSUMPTIONS
    2.5 RISK ASSESSMENT 
          TABLE 2 RESPIRATORY CARE DEVICES MARKET: RISK ASSESSMENT ANALYSIS
    2.6 RESEARCH LIMITATIONS 
    2.7 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 76)
    FIGURE 17 RESPIRATORY CARE DEVICES MARKET SIZE, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 18 RESPIRATORY CARE DEVICES INDUSTRY, BY DISEASE INDICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 19 RESPIRATORY CARE DEVICES MARKET SIZE, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 20 RESPIRATORY CARE DEVICES MARKET SHARE: GEOGRAPHICAL SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 80)
    4.1 RESPIRATORY CARE DEVICES MARKET OVERVIEW 
          FIGURE 21 HIGH TOBACCO CONSUMPTION TO BOOST MARKET GROWTH THROUGHOUT FORECAST PERIOD
    4.2 NORTH AMERICA: RESPIRATORY CARE DEVICES INDUSTRY, BY TYPE (2022) 
          FIGURE 22 THERAPEUTIC RESPIRATORY CARE DEVICES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 23 INDIA TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD
    4.4 RESPIRATORY CARE DEVICES MARKET SHARE: REGIONAL MIX 
          FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET THROUGHOUT FORECAST PERIOD
    4.5 MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER CAGRS DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 84)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 26 RESPIRATORY CARE DEVICES MARKET SHARE: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising prevalence of respiratory diseases
                               5.2.1.1.1 Rapid growth in global geriatric population
                                              FIGURE 27 GLOBAL GERIATRIC POPULATION, BY REGION
                               5.2.1.1.2 Urbanization and growing pollution levels
                                              FIGURE 28 ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE
                               5.2.1.1.3 Growing tobacco consumption
                                              TABLE 3 REGION-WISE DATA ON LIFESTYLE DISEASES
                               5.2.1.1.4 Increased adoption of sedentary lifestyles
                    5.2.1.2 Surging incidence rate of preterm births
                                TABLE 4 TOP 10 COUNTRIES WITH HIGHEST NUMBER OF PRETERM BIRTHS
                                TABLE 5 TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS
                    5.2.1.3 Growing outbreaks of infectious diseases affecting respiratory systems
                    5.2.1.4 Rising population with sleep disorders
                    5.2.1.5 Improved patient outcomes using respiratory care devices
                    5.2.1.6 Surging R&D investments for technological advancement of medical devices
                                TABLE 6 PRODUCT LAUNCHES
           5.2.2 RESTRAINTS
                    5.2.2.1 Unfavorable reimbursement scenario for respiratory care diagnostics
                    5.2.2.2 Availability of low-cost products from local manufacturers
                    5.2.2.3 High cost of CPAP machines
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing demand for home care therapeutic devices
                    5.2.3.2 Market growth opportunities in Asia Pacific and Latin America
                    5.2.3.3 Increasing preference for self-testing
                    5.2.3.4 Growing awareness about ill effects of untreated sleep apnea
                                TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA
           5.2.4 CHALLENGES
                    5.2.4.1 Low awareness and lack of diagnosis of respiratory diseases
                    5.2.4.2 Harmful effects of certain respiratory care devices on neonates
                    5.2.4.3 Lack of patient compliance with CPAP therapy
    5.3 INDUSTRY TRENDS 
           5.3.1 RISING DEMAND FOR ENHANCED COMPACT AND PORTABLE DEVICES
           5.3.2 KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSION
           5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATION
           5.3.4 RISING ADOPTION OF NON-INVASIVE VENTILATION
                    FIGURE 29 IMPACT OF INNOVATIVE SOLUTIONS
                    FIGURE 30 INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT
    5.4 REGULATORY ANALYSIS 
           5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.4.2 NORTH AMERICA
                    5.4.2.1 US
                                TABLE 11 US: CLASSIFICATION OF MEDICAL EQUIPMENT
                                TABLE 12 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.4.2.2 Canada
                                TABLE 13 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.4.3 EUROPE
                    TABLE 14 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.4.4 ASIA PACIFIC
                    5.4.4.1 Japan
                                TABLE 15 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.4.4.2 China
                                TABLE 16 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.4.4.3 India
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 31 RESPIRATORY CARE DEVICES INDUSTRY: ECOSYSTEM ANALYSIS
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 32 MARKET: VALUE CHAIN ANALYSIS
    5.7 IMPACT OF COVID-19 ON MARKET 
    5.8 TECHNOLOGY ANALYSIS 
           5.8.1 E-NOSE TECHNOLOGY
           5.8.2 MEMS TECHNOLOGY
           5.8.3 ELECTROCHEMICAL TECHNOLOGY
           5.8.4 WIRELESS GAS SENSOR TECHNOLOGY
    5.9 PATENT ANALYSIS 
           5.9.1 PATENT PUBLICATION TRENDS FOR RESPIRATORY CARE DEVICES
                    FIGURE 33 PATENT PUBLICATION TRENDS (2015–2023)
           5.9.2 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY (2015–2023)
                    TABLE 17 TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY
           5.9.3 MARKET: TOP APPLICANTS
                    FIGURE 34 TOP APPLICANTS FOR RESPIRATORY CARE DEVICES PATENTS (2015–2023)
    5.10 TRADE ANALYSIS 
           TABLE 18 TOP EXPORTERS OF MEDICAL VENTILATORS, CPAP, BIPAP, AND OXYGEN CONCENTRATORS, 2021
    5.11 CASE STUDY ANALYSIS 
           TABLE 19 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. EMERGING ECONOMIES
           TABLE 20 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS
    5.12 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 21 PORTER’S FIVE FORCES ANALYSIS
           5.12.1 THREAT OF NEW ENTRANTS
           5.12.2 THREAT OF SUBSTITUTES
           5.12.3 BARGAINING POWER OF SUPPLIERS
           5.12.4 BARGAINING POWER OF BUYERS
           5.12.5 INTENSITY OF COMPETITIVE RIVALRY
    5.13 KEY CONFERENCES AND EVENTS, 2023–2024 
           5.13.1 MARKET: LIST OF KEY CONFERENCES AND EVENTS
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     TABLE 22 STAKEHOLDERS IN BUYING PROCESS FOR RESPIRATORY CARE DEVICES
                     TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES
           5.14.2 BUYING CRITERIA
                     FIGURE 35 KEY BUYING CRITERIA FOR RESPIRATORY DEVICES
                     TABLE 24 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES
    5.15 PRICING ANALYSIS 
           TABLE 25 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES
    5.16 UNMET NEEDS PERTAINING TO RESPIRATORY CARE DEVICES 
           TABLE 26 MARKET: UNMET NEEDS
           5.16.1 END USER EXPECTATIONS
                     TABLE 27 MARKET: END USER EXPECTATIONS
    5.17 APPLICATION OF ARTIFICIAL INTELLIGENCE IN RESPIRATORY CARE DEVICES 
           TABLE 28 MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE
           5.17.1 FUTURE OF HEALTHCARE—BIG DATA AND ARTIFICIAL INTELLIGENCE
    5.18 REIMBURSEMENT SCENARIO 
           TABLE 29 MARKET: REIMBURSEMENT SCENARIO
 
6 GLOBAL RESPIRATORY CARE DEVICES MARKET SHARE, BY PRODUCT (Page No. - 122)
    6.1 INTRODUCTION 
          TABLE 30 RESPIRATORY CARE DEVICES INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 31 MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.2 THERAPEUTIC RESPIRATORY CARE DEVICES 
          TABLE 32 RESPIRATORY CARE DEVICES MARKET SHARE, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 33 RESPIRATORY CARE DEVICES MARKET FORECAST, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 PAP DEVICES
                    TABLE 34 PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 35 PAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 36 PAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.1.1 CPAP devices
                               6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand
                                              TABLE 37 MAJOR PLAYERS OFFERING CPAP DEVICES IN MARKET
                                              TABLE 38 CPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 39 CPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.1.2 APAP devices
                               6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market
                                              TABLE 40 MAJOR PLAYERS OFFERING APAP DEVICES IN MARKET
                                              TABLE 41 APAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 42 APAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.1.3 BiPAP devices
                               6.2.1.3.1 Increasing number of hospitals to strengthen market
                                              TABLE 43 MAJOR PLAYERS OFFERING BIPAP DEVICES IN MARKET
                                              TABLE 44 BIPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 45 BIPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.2.2 VENTILATORS
                    TABLE 46 VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 47 VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 48 VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.2.1 ICU ventilators
                                TABLE 49 MAJOR PLAYERS OFFERING ICU VENTILATORS IN MARKET
                                TABLE 50 ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 51 ICU VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 52 ICU VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                               6.2.2.1.1 High-end ventilators
                                             6.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive market
                                                               TABLE 53 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                                               TABLE 54 HIGH-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                               6.2.2.1.2 Mid-end ventilators
                                             6.2.2.1.2.1 Better affordability and accessibility of mid-end ventilators than high-end models to support market growth
                                                               TABLE 55 MID-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                                               TABLE 56 MID-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                               6.2.2.1.3 Basic ventilators
                                             6.2.2.1.3.1 Expanding access to critical healthcare facilities in developing countries to spur demand
                                                               TABLE 57 BASIC VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                                               TABLE 58 BASIC VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.2.2 Portable/Transportable ventilators
                               6.2.2.2.1 Increasing demand for home care to boost segmental growth
                                              TABLE 59 MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS IN MARKET
                                              TABLE 60 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 61 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.2.3 NEBULIZERS
                    TABLE 62 MAJOR PLAYERS OFFERING NEBULIZERS IN MARKET
                    TABLE 63 NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 64 NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 65 NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.3.1 Jet nebulizers
                               6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market size
                                              TABLE 66 JET NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 67 JET NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.3.2 Mesh nebulizers
                               6.2.3.2.1 Deployment of advanced aerosolization technology to drive market
                                              TABLE 68 MESH NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 69 MESH NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.3.3 Ultrasonic nebulizers
                               6.2.3.3.1 Adjus                                              TABLE settings for particle size and treatment duration to boost market
                                              TABLE 70 ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 71 ULTRASONIC NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.2.4 HUMIDIFIERS
                    TABLE 72 HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 73 HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 74 HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.4.1 Heated humidifiers
                               6.2.4.1.1 Ease of control and customizability to grow market
                                              TABLE 75 MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS IN MARKET
                                              TABLE 76 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 77 HEATED HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.4.2 Passover humidifiers
                               6.2.4.2.1 Minimal maintenance and simple technology to spur demand
                                              TABLE 78 MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS IN MARKET
                                              TABLE 79 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 80 PASSOVER HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.2.5 OXYGEN CONCENTRATORS
                    TABLE 81 MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS IN MARKET
                    TABLE 82 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 83 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 84 OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.5.1 Fixed oxygen concentrators
                               6.2.5.1.1 Better access to healthcare services to grow demand
                                              TABLE 85 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 86 FIXED OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.5.2 Portable oxygen concentrators
                               6.2.5.2.1 Low weight and easy setup to drive segmental growth
                                              TABLE 87 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 88 PORTABLE OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.2.6 INHALERS
                    TABLE 89 INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 90 INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 91 INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.6.1 Metered-dose inhalers (MDIs)
                               6.2.6.1.1 Ongoing advancements in MDI technology to support market growth
                                              TABLE 92 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 93 METERED-DOSE INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.2.6.2 Dry powder inhalers (DPIs)
                               6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth
                                              TABLE 94 DRY POWDER INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 95 DRY POWDER INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.2.7 REUSABLE RESUSCITATORS
                    6.2.7.1 Disposable and reusable nature to drive demand
                                TABLE 96 MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS IN MARKET
                                TABLE 97 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 98 REUSABLE RESUSCITATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.2.8 NITRIC OXIDE DELIVERY UNITS
                    6.2.8.1 Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market
                                TABLE 99 MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS IN MARKET
                                TABLE 100 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 101 NITRIC OXIDE DELIVERY UNITS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.2.9 OXYGEN HOODS
                    6.2.9.1 Growing prevalence of respiratory diseases in kids to drive market growth
                                TABLE 102 MAJOR PLAYERS OFFERING OXYGEN HOODS IN MARKET
                                TABLE 103 OXYGEN HOODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 104 OXYGEN HOODS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
    6.3 MONITORING DEVICES 
          TABLE 105 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 106 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 PULSE OXIMETERS
TABLE 107 MAJOR PLAYERS OFFERING PULSE OXIMETERS IN MARKET
TABLE 108 PULSE OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 PULSE OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 PULSE OXIMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.3.1.1 Pulse oximeter sensors
                               6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth
                                              TABLE 111 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 112 PULSE OXIMETER SENSORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
                    6.3.1.2 Pulse oximeter equipment
                               6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand
                                              TABLE 113 MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT IN MARKET
                                              TABLE 114 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 115 PULSE OXIMETER EQUIPMENT MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.3.2 CAPNOGRAPHS
                    6.3.2.1 Ongoing R&D on capnographs to offer lucrative growth opportunities
                                TABLE 116 MAJOR PLAYERS OFFERING CAPNOGRAPHS IN MARKET
                                TABLE 117 CAPNOGRAPHS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 118 CAPNOGRAPHS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.3.3 GAS ANALYZERS
                    6.3.3.1 Increasing demand for point-of-care testing to drive demand
                                TABLE 119 MAJOR PLAYERS OFFERING GAS ANALYZERS IN MARKET
                                TABLE 120 GAS ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 121 GAS ANALYZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
    6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 
          TABLE 122 MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 123 MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.4.1 SPIROMETERS
                    6.4.1.1 Rising technological advancements in spirometers to support market growth
                                TABLE 124 MAJOR PLAYERS OFFERING SPIROMETERS IN MARKET
                                TABLE 125 SPIROMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 126 SPIROMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES)
                    6.4.2.1 Rising incidence of obstructive sleep apnea to drive demand
                                TABLE 127 MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES IN MARKET
                                TABLE 128 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 129 POLYSOMNOGRAPHY DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.4.3 PEAK FLOW METERS
                    6.4.3.1 Low-cost and uncomplicated nature to drive segmental growth
                                TABLE 130 MAJOR PLAYERS OFFERING PEAK FLOW METERS IN MARKET
                                TABLE 131 PEAK FLOW METERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 132 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
           6.4.4 OTHER DIAGNOSTIC DEVICES
                    TABLE 133 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.5 CONSUMABLES & ACCESSORIES 
          TABLE 134 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 135 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.5.1 MASKS
                    TABLE 136 MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 137 MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.5.1.1 Reusable masks
                               6.5.1.1.1 Growing concerns related to air pollution to grow demand
                                              TABLE 138 REUSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.5.1.2 Disposable masks
                               6.5.1.2.1 Stringent government mandates on wearing masks to spur demand
                                              TABLE 139 DISPOSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.5.2 DISPOSABLE RESUSCITATORS
                    6.5.2.1 Growing focus on reducing cross-contamination cases in patients to foster segmental growth
                                TABLE 140 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.5.3 TRACHEOSTOMY TUBES
                    6.5.3.1 Introduction of new and advanced products with ergonomic designs to drive market growth
                                TABLE 141 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.5.4 BREATHING CIRCUITS
                    6.5.4.1 Healthcare professionals’ efforts to improve infection control practices to grow demand
                                TABLE 142 BREATHING CIRCUITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.5.5 NASAL CANNULAE
                    6.5.5.1 Increasing focus on minimally invasive surgery techniques to fuel demand
                                TABLE 143 NASAL CANNULAE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.5.6 OTHER CONSUMABLES & ACCESSORIES
                    TABLE 144 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
GLOBAL RESPIRATORY CARE DEVICES MARKET FORECAST, BY DISEASE INDICATION (Page No. - 206)
    7.1 INTRODUCTION 
          TABLE 145 RESPIRATORY CARE DEVICES INDUSTRY, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
    7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 
           7.2.1 RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET
                    TABLE 146 MARKET FOR COPD, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 SLEEP APNEA 
           7.3.1 GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH
                    TABLE 147 COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS
                    TABLE 148 MARKET FOR SLEEP APNEA, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 ASTHMA 
           7.4.1 INCREASING INCIDENCE OF COPD TO DRIVE MARKET
                    TABLE 149 MARKET FOR ASTHMA, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 INFECTIOUS DISEASES 
           7.5.1 GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH
                    TABLE 150 INCIDENCE OF TB (RATE PER 100,000 POPULATION)
                    TABLE 151 MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
    7.6 OTHER DISEASE INDICATIONS 
          TABLE 152 MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
 
GLOBAL RESPIRATORY CARE DEVICES MARKET FORECAST, BY END USER (Page No. - 215)
    8.1 INTRODUCTION 
          TABLE 153 RESPIRATORY CARE DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    8.2 HOSPITALS 
           8.2.1 GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET
                    TABLE 154 MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 HOME CARE SETTINGS 
           8.3.1 INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH
                    TABLE 155 MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 AMBULATORY CARE CENTERS (ACCS) 
           8.4.1 IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET
                    TABLE 156 MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 OTHER END USERS 
          TABLE 157 RESPIRATORY CARE DEVICES MARKET FORECAST FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
GLOBAL RESPIRATORY CARE DEVICES MARKET FORECAST, BY REGION (Page No. - 222)
    9.1 INTRODUCTION 
          FIGURE 36 RESPIRATORY CARE DEVICES INDUSTRY: REGIONAL GROWTH OPPORTUNITIES
          TABLE 158 MARKET, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 37 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
          TABLE 159 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 160 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 161 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 162 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 163 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 164 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 165 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 166 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 167 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 168 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 169 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 170 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 171 NORTH AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 172 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 173 NORTH AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 174 NORTH AMERICA: RESPIRATORY CARE DEVICES INDUSTRY, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
          TABLE 175 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET TRENDS, BY END USER, 2021–2028 (USD MILLION)
           9.2.1 NORTH AMERICA: RECESSION IMPACT
           9.2.2 US
                    9.2.2.1 Rapid growth in geriatric population to boost market
                                TABLE 176 US: KEY MACROINDICATORS
                                TABLE 177 US: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 178 US: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 179 US: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 180 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 181 US: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 182 US: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 183 US: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 184 US: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 185 US: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 186 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 187 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 188 US: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 189 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 190 US: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 191 US: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 192 US: RESPIRATORY CARE DEVICES MARKET TRENDS, BY END USER, 2021–2028 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Large pool of undiagnosed patients to drive market
                                TABLE 193 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
                                TABLE 194 CANADA: KEY MACROINDICATORS
                                TABLE 195 CANADA: RESPIRATORY CARE DEVICES MARKET TRENDS, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 196 CANADA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 197 CANADA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 198 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 199 CANADA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 200 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 201 CANADA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 202 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 203 CANADA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 204 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 205 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 206 CANADA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 207 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 208 CANADA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 209 CANADA: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 210 CANADA: RESPIRATORY CARE DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    9.3 EUROPE 
          TABLE 211 EUROPE: RESPIRATORY CARE DEVICES MARKET TRENDS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 212 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 213 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 214 EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 215 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 216 EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 217 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 218 EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 219 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 220 EUROPE: NEBULIZER MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 221 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 222 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 223 EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 224 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 225 EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 226 EUROPE: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
          TABLE 227 EUROPE: RESPIRATORY CARE DEVICES MARKET TRENDS, BY END USER, 2021–2028 (USD MILLION)
           9.3.1 EUROPE: RECESSION IMPACT
           9.3.2 GERMANY
                    9.3.2.1 Increasing public healthcare expenditure to foster market growth
                                TABLE 228 GERMANY: KEY MACROINDICATORS
                                TABLE 229 GERMANY: RESPIRATORY CARE DEVICES MARKET OVERVIEW, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 230 GERMANY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 231 GERMANY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 232 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 233 GERMANY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 234 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 235 GERMANY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 236 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 237 GERMANY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 238 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 239 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 240 GERMANY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 241 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 242 GERMANY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 243 GERMANY: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 244 GERMANY: RESPIRATORY CARE DEVICES MARKET OVERVIEW, BY END USER, 2021–2028 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 High prevalence of COPD to surge demand
                                TABLE 245 FRANCE: KEY MACROINDICATORS
                                TABLE 246 FRANCE: RESPIRATORY CARE DEVICES MARKET OVERVIEW, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 247 FRANCE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 248 FRANCE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 249 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 250 FRANCE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 251 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 252 FRANCE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 253 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 254 FRANCE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 255 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 256 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 257 FRANCE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 258 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 259 FRANCE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 260 FRANCE: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 261 FRANCE: RESPIRATORY CARE DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.3.4 UK
                    9.3.4.1 Growing demand for minimally invasive surgeries to drive market
                                TABLE 262 UK: KEY MACROINDICATORS
                                TABLE 263 UK: RESPIRATORY CARE DEVICES MARKET OVERVIEW, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 264 UK: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 265 UK: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 266 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 267 UK: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 268 UK: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 269 UK: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 270 UK: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 271 UK: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 272 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 273 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 274 UK: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 275 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 276 UK: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 277 UK: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 278 UK: RESPIRATORY CARE DEVICES MARKET GROWTH, BY END USER, 2021–2028 (USD MILLION)
           9.3.5 ITALY
                    9.3.5.1 Growing involvement of private sector in healthcare market to drive market
                                TABLE 279 ITALY: KEY MACROINDICATORS
                                TABLE 280 ITALY: RESPIRATORY CARE DEVICES MARKET GROWTH, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 281 ITALY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 282 ITALY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 283 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 284 ITALY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 285 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 286 ITALY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 287 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 288 ITALY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 289 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 290 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 291 ITALY: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 292 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 293 ITALY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 294 ITALY: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 295 ITALY: RESPIRATORY CARE DEVICES MARKET GROWTH, BY END USER, 2021–2028 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand
                                TABLE 296 SPAIN: KEY MACROINDICATORS
                                TABLE 297 SPAIN: RESPIRATORY CARE DEVICES MARKET GROWTH, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 298 SPAIN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 299 SPAIN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 300 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 301 SPAIN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 302 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 303 SPAIN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 304 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 305 SPAIN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 306 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 307 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 308 SPAIN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 309 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 310 SPAIN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 311 SPAIN: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 312 SPAIN: RESPIRATORY CARE DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.3.7 REST OF EUROPE
                    TABLE 313 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET GROWTH, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 314 REST OF EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 315 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 316 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 317 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 318 REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 319 REST OF EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 320 REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 321 REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 322 REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 323 REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 324 REST OF EUROPE: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 325 REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 326 REST OF EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 327 REST OF EUROPE: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                    TABLE 328 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET REPORT, BY END USER, 2021–2028 (USD MILLION)
    9.4 ASIA PACIFIC 
          FIGURE 38 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
          TABLE 329 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 330 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 331 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 332 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 333 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 334 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 335 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 336 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 337 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 338 ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 339 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 340 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 341 ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 342 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 343 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 344 ASIA PACIFIC: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
          TABLE 345 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET REPORT, BY END USER, 2021–2028 (USD MILLION)
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
           9.4.2 JAPAN
                    9.4.2.1 Availability of universal healthcare reimbursement policy to drive market
                                TABLE 346 JAPAN: KEY MACROINDICATORS
                                TABLE 347 JAPAN: RESPIRATORY CARE DEVICES MARKET REPORT, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 348 JAPAN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 349 JAPAN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 350 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 351 JAPAN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 352 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 353 JAPAN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 354 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 355 JAPAN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 356 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 357 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 358 JAPAN: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 359 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 360 JAPAN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 361 JAPAN: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 362 JAPAN: RESPIRATORY CARE DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.4.3 CHINA
                    9.4.3.1 Initiatives to modernize healthcare system and reimbursement facilities to support market growth
                                TABLE 363 CHINA: KEY MACROINDICATORS
                                TABLE 364 CHINA: RESPIRATORY CARE DEVICES MARKET REPORT, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 365 CHINA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 366 CHINA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 367 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 368 CHINA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 369 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 370 CHINA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 371 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 372 CHINA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 373 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 374 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 375 CHINA: RESPIRATORY CARE DEVICES MARKET PREDICTION, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 376 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 377 CHINA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 378 CHINA: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 379 CHINA: RESPIRATORY CARE DEVICES MARKET REPORT, BY END USER, 2021–2028 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Increasing focus of global players on domestic market to drive market
                                TABLE 380 INDIA: KEY MACROINDICATORS
                                TABLE 381 INDIA: RESPIRATORY CARE DEVICES MARKET DEMAND, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 382 INDIA: EVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 383 INDIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 384 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 385 INDIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 386 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 387 INDIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 388 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 389 INDIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 390 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 391 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 392 INDIA: RESPIRATORY CARE DEVICES MARKET PREDICTION, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 393 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 394 INDIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 395 INDIA: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 396 INDIA: RESPIRATORY CARE DEVICES MARKET DEMAND, BY END USER, 2021–2028 (USD MILLION)
           9.4.5 AUSTRALIA
                    9.4.5.1 High prevalence of chronic lung diseases to drive demand
                                TABLE 397 AUSTRALIA: KEY MACROINDICATORS
                                TABLE 398 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET DEMAND, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 399 AUSTRALIA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 400 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 401 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 402 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 403 AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 404 AUSTRALIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 405 AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 406 AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 407 AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 408 AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 409 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET PREDICTION, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 410 AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 411 AUSTRALIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 412 AUSTRALIA: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 413 AUSTRALIA: RESPIRATORY CARE DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.4.6 SOUTH KOREA
                    9.4.6.1 Expanding geriatric population to fuel market
                                TABLE 414 SOUTH KOREA: KEY MACROINDICATORS
                                TABLE 415 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET DEMAND, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 416 SOUTH KOREA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 417 SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 418 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 419 SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 420 SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 421 SOUTH KOREA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 422 SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 423 SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 424 SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 425 SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 426 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET PREDICTION, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 427 SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 428 SOUTH KOREA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 429 SOUTH KOREA: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 430 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET DEMAND, BY END USER, 2021–2028 (USD MILLION)
           9.4.7 REST OF ASIA PACIFIC
                    TABLE 431 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET ANALYSIS, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 432 REST OF ASIA PACIFIC: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 433 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 434 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 435 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 436 REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 437 REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 438 REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 439 REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 440 REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 441 REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 442 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET PREDICTION, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 443 REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 444 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 445 REST OF ASIA PACIFIC: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                    TABLE 446 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET ANALYSIS, BY END USER, 2021–2028 (USD MILLION)
    9.5 LATIN AMERICA 
          TABLE 447 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 448 LATIN AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 449 LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 450 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 451 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 452 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 453 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 454 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 455 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 456 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 457 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 458 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 459 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET SEGMENTATION, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 460 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 461 LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 462 LATIN AMERICA: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
          TABLE 463 LATIN AMERICA: RESPIRATORY CARE DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.5.1 LATIN AMERICA: RECESSION IMPACT
           9.5.2 BRAZIL
                    9.5.2.1 Government initiatives to improve healthcare sector to drive market
                                TABLE 464 BRAZIL: KEY MACROINDICATORS
                                TABLE 465 BRAZIL: RESPIRATORY CARE DEVICES MARKET ANALYSIS, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 466 BRAZIL: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 467 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 468 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 469 BRAZIL: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 470 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 471 BRAZIL: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 472 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 473 BRAZIL: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 474 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 475 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 476 BRAZIL: RESPIRATORY CARE DEVICES MARKET SEGMENTATION, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 477 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 478 BRAZIL: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 479 BRAZIL: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 480 BRAZIL: RESPIRATORY CARE DEVICES MARKET ANALYSIS, BY END USER, 2021–2028 (USD MILLION)
           9.5.3 MEXICO
                    9.5.3.1 Rising obesity rate to increase incidence of respiratory diseases
                                TABLE 481 MEXICO: KEY MACROINDICATORS
                                TABLE 482 MEXICO: RESPIRATORY CARE DEVICES MARKET RESEARCH, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 483 MEXICO: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 484 MEXICO: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 485 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 486 MEXICO: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 487 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 488 MEXICO: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 489 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 490 MEXICO: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 491 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 492 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 493 MEXICO: RESPIRATORY CARE DEVICES MARKET SEGMENTATION, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 494 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 495 MEXICO: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 496 MEXICO: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                                TABLE 497 MEXICO: RESPIRATORY CARE DEVICES MARKET RESEARCH, BY END USER, 2021–2028 (USD MILLION)
           9.5.4 REST OF LATIN AMERICA
                    TABLE 498 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET RESEARCH, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 499 REST OF LATIN AMERICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 500 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 501 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 502 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 503 REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 504 REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 505 REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 506 REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 507 REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 508 REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 509 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET SEGMENTATION, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 510 REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 511 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 512 REST OF LATIN AMERICA: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                    TABLE 513 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS
                    TABLE 514 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET RESEARCH, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 515 MIDDLE EAST & AFRICA: MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 516 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 517 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 518 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 519 MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 520 MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 521 MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 522 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 523 MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 524 MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 525 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET SEGMENTATION, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 526 MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 527 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 528 MIDDLE EAST & AFRICA: MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)
                    TABLE 529 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET RESEARCH, BY END USER, 2021–2028 (USD MILLION)
           9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
10 COMPETITIVE LANDSCAPE (Page No. - 364)
     10.1 INTRODUCTION 
     10.2 RIGHT TO WIN/KEY STRATEGIES 
     10.3 STRATEGIES ADOPTED BY KEY PLAYERS 
     10.4 REVENUE ANALYSIS FOR TOP FIVE MARKET PLAYERS 
             FIGURE 39 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN RESPIRATORY CARE DEVICES MARKET
     10.5 MARKET SHARE ANALYSIS 
             FIGURE 40 RESPIRATORY CARE DEVICES INDUSTRY SHARE, BY KEY PLAYER (2022)
             FIGURE 41 SHARE OF LEADING COMPANIES IN GLOBAL THERAPEUTIC RESPIRATORY CARE DEVICES MARKET (2022)
             FIGURE 42 SHARE OF LEADING COMPANIES IN GLOBAL MONITORING DEVICES MARKET (2022)
             FIGURE 43 SHARE OF LEADING COMPANIES IN GLOBAL DIAGNOSTIC RESPIRATORY CARE DEVICES INDUSTRY (2022)
     10.6 COMPANY EVALUATION MATRIX 
             10.6.1 STARS
             10.6.2 EMERGING LEADERS
             10.6.3 PERVASIVE PLAYERS
             10.6.4 PARTICIPANTS
                        FIGURE 44 RESPIRATORY CARE DEVICES INDUSTRY: COMPETITIVE LEADERSHIP MATRIX, 2022
     10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022) 
             10.7.1 PROGRESSIVE COMPANIES
             10.7.2 DYNAMIC COMPANIES
             10.7.3 STARTING BLOCKS
             10.7.4 RESPONSIVE COMPANIES
                        FIGURE 45 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2022
     10.8 COMPETITIVE BENCHMARKING 
             TABLE 530 RESPIRATORY CARE DEVICES INDUSTRY: KEY STARTUPS/SMES
             10.8.1 COMPANY FOOTPRINT
                        TABLE 531 FOOTPRINT OF COMPANIES, BY OFFERING (25 COMPANIES)
                        TABLE 532 FOOTPRINT OF COMPANIES, BY DISEASE INDICATION (25 COMPANIES)
                        TABLE 533 FOOTPRINT OF COMPANIES, BY END USER (25 COMPANIES)
                        FIGURE 46 OVERALL FOOTPRINT OF COMPANIES (25 COMPANIES)
             10.8.2 COMPETITIVE SCENARIOS AND TRENDS
             10.8.3 PRODUCT LAUNCHES
                        TABLE 534 RESPIRATORY CARE DEVICES INDUSTRY: PRODUCT LAUNCHES (2019–2023)
             10.8.4 DEALS
                        TABLE 535 RESPIRATORY CARE DEVICES MARKET: DEALS (2019–2023)
 
11 COMPANY PROFILES (Page No. - 381)
     11.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             11.1.1 KONINKLIJKE PHILIPS N.V.
                        TABLE 536 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                        FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
             11.1.2 MEDTRONIC
                        TABLE 537 MEDTRONIC: BUSINESS OVERVIEW
                        FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2022)
             11.1.3 RESMED
                        TABLE 538 RESMED: BUSINESS OVERVIEW
                        FIGURE 49 RESMED: COMPANY SNAPSHOT (2022)
             11.1.4 MASIMO
                        TABLE 539 MASIMO: BUSINESS OVERVIEW
                        FIGURE 50 MASIMO: COMPANY SNAPSHOT (2022)
             11.1.5 FISHER & PAYKEL HEALTHCARE LIMITED
                        TABLE 540 FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW
                        FIGURE 51 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2022)
             11.1.6 DRÄGERWERK AG & CO. KGAA
                        TABLE 541 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW
                        FIGURE 52 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)
             11.1.7 GETINGE
                        TABLE 542 GETINGE: BUSINESS OVERVIEW
                        FIGURE 53 GETINGE: COMPANY SNAPSHOT (2022)
             11.1.8 NIHON KOHDEN CORPORATION
                        TABLE 543 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
                        FIGURE 54 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.9 GE HEALTHCARE
                        TABLE 544 GE HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 55 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
             11.1.10 VYAIRE MEDICAL, INC.
                        TABLE 545 VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW
             11.1.11 BAXTER INTERNATIONAL, INC.
                        TABLE 546 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
                        FIGURE 56 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)
             11.1.12 ADAPTHEALTH, LLC
                        TABLE 547 ADAPTHEALTH, LLC: BUSINESS OVERVIEW
                        FIGURE 57 ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2022)
             11.1.13 ROTECH HEALTHCARE, INC.
                        TABLE 548 ROTECH HEALTHCARE INC.: BUSINESS OVERVIEW
             11.1.14 TELEFLEX INCORPORATED
                        TABLE 549 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 58 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
             11.1.15 AIR LIQUIDE
                        TABLE 550 AIR LIQUIDE: BUSINESS OVERVIEW
                        FIGURE 59 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
     11.2 OTHER PLAYERS 
             11.2.1 INVACARE CORPORATION
                        TABLE 551 INVACARE CORPORATION: BUSINESS OVERVIEW
                        FIGURE 60 INVACARE CORPORATION: COMPANY SNAPSHOT (2022)
             11.2.2 ICU MEDICAL
                        TABLE 552 ICU MEDICAL: BUSINESS OVERVIEW
                        FIGURE 61 ICU MEDICAL: COMPANY SNAPSHOT (2022)
             11.2.3 HAMILTON MEDICAL AG
                        TABLE 553 HAMILTON MEDICAL AG: BUSINESS OVERVIEW
             11.2.4 APEX MEDICAL CORP
                        TABLE 554 APEX MEDICAL CORP: BUSINESS OVERVIEW
             11.2.5 MEDLINE INDUSTRIES, LP
                        TABLE 555 MEDLINE INDUSTRIES, LP: BUSINESS OVERVIEW
             11.2.6 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH
                        TABLE 556 HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH: BUSINESS OVERVIEW
             11.2.7 NONIN
             11.2.8 ALLIED MEDICAL LLC
             11.2.9 DRIVE DEVILBISS HEALTHCARE
             11.2.10 OMRON HEALTHCARE, INC.
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 458)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the respiratory care devices market. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Extensive primary research was conducted after obtaining information regarding the respiratory care devices market scenario through secondary research. Several primary interviews were conducted with market experts from both, the demand and supply sides across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Primary data was collected through questionnaires, emails, and telephonic interview. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors, from business development, marketing, product development/innovation teams, and related key executives from respiratory care devices providers; system integrators; component providers; distributors; and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. The primary sources from the supply side and demand side are detailed below.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Interviews: Supply-Side Participants, by Company Type, Designation, and Region

Supply side:

Respiratory Care Devices Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

Breakdown of Primary Interviews: Demand-Side Participants, by End User, Designation, and Region

Demand Side:

Respiratory Care Devices Market Size, and Share

Note: Others include department heads, research scientists, and professors.

Market Size Estimation

The total size of the respiratory care devices market was arrived at after data triangulation from two different approaches, as mentioned below. After each approach, the weighted average of all approaches was taken based on the level of assumptions used in each approach.

Global Respiratory Care Devices Market Size: Bottom-Up Approach

Respiratory Care Devices Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Respiratory Care Devices Market Size: Top-Down Approach

Respiratory Care Devices Market Size, and Share

Data Triangulation

After arriving at the market size, the total market was divided into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.

Market Definition

Respiratory care is a healthcare specialty that provides diagnostic evaluation, management, control, therapy, and monitoring of cardiopulmonary system diseases and disorders. Respiratory care devices are extensively used in general & surgical wards and ICUs as a life support measure.  Respiratory assist devices include devices intended to help patients in need of support for breathing, removal of carbon dioxide, and therapy to reduce disuse atrophy of abdominal wall muscles.

Key Stakeholders

  • Respiratory care device manufacturers and distributors
  • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
  • Research institutes
  • Contract manufacturing organizations (CMOs)
  • Government associations
  • Market research and consulting firms
  • Venture capitalists and investors

Objectives of the Study

  • To define, describe, segment, and forecast the global respiratory care devices market on the basis of product, disease indications, end user, and region
  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall respiratory care devices market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players functioning in this market
  • To forecast the size of the respiratory care devices market in five main regions as well as country-wise segmentation (North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa)
  • To profile key players in the respiratory care devices market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, and agreements of the leading players in the respiratory care devices market

Available customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the RoE respiratory care devices market into Austria, Finland, and others
  • Further breakdown of the RoLATAM respiratory care devices market into Argentina, Colombia, Chile, and others

Competitive Landscape Assessment

  • Market share analysis for the North America and Europe region, which provides market shares of the top 3–5 key players in the respiratory care devices market.
  • Competitive leadership mapping for established players in the US
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 1583
Published ON
Sep, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Respiratory Care Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback